CHARACTERIZATION OF A NEW CELL-LINE (ESKOL) RESEMBLING HAIRY-CELL LEUKEMIA - A MODEL FOR ONCOGENE REGULATION AND LATE B-CELL DIFFERENTIATION

被引:35
作者
HARVEY, W
SROUR, EF
TURNER, R
CAREY, R
MAZE, R
STARRETT, B
KANAGALA, R
PEREIRA, D
MERCHANT, P
TAYLOR, M
JANSEN, J
机构
[1] INDIANA UNIV,SCH MED,DEPT MED HEMATOL ONCOL,INDIANAPOLIS,IN 46202
[2] INDIANA UNIV,DEPT BIOL SCI,BLOOMINGTON,IN 47405
关键词
INTERFERON; HAIRY-CELL LEUKEMIA; C-FOS; H-RAS; C-MYC; ONCOGENES;
D O I
10.1016/0145-2126(91)90077-7
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
A B-lymphoblastoid cell line ESKOL, composed of differentiated cells resembling hairy-cell leukemia (HCL) has been established from the peripheral blood (PB) of a HCL patient. Morphologically, ESKOL cells share several features with HCL B cells. Flow cytometric analysis revealed that ESKOL cells express HC2, CD21, PCA-1, CD24, FMC7, and CD25. Analysis by Northern-blot hybridization indicated that cultured cells expressed the oncogenes c-myc, H-ras and c-fos. RNA from 3T3 cells transfected with ESKOL DNA hybridized with H-ras and c-fos DNA probes. The ESKOL cells cultured in the presence of increasing concentrations, of alpha interferon demonstrated a decrease in the rate of cellular growth and an increase in the expression of CD21, CD25, FMC7 and PCA-1. Scanning electron microscopy revealed that cells incubated in the presence of alpha interferon underwent membranous changes with a loss of villosity. These observations suggest that IFN tends to drive HC out of their developmental arrest towards maturation.
引用
收藏
页码:733 / 744
页数:12
相关论文
共 44 条
[1]  
ANDERSON KC, 1985, BLOOD, V65, P620
[2]  
ANDERSSON LC, 1981, LEUKEMIA MARKERS, P297
[3]  
BLICK M, 1984, BLOOD, V64, P1234
[4]   SERA OF PATIENTS WITH HAIRY-CELL LEUKEMIA IMMUNOPRECIPITATE EBV-RELATED ANTIGENS [J].
CASAREALE, D ;
SAKAMOTO, K ;
AIBA, M ;
KATAYAMA, I ;
PURTILO, DT ;
HUMPHREYS, RE .
LEUKEMIA RESEARCH, 1981, 5 (02) :107-+
[5]  
CATOVSKY D, 1981, BLOOD, V58, P406
[6]   FBJ MURINE OSTEO-SARCOMA VIRUS - IDENTIFICATION AND MOLECULAR-CLONING OF BIOLOGICALLY-ACTIVE PROVIRAL DNA [J].
CURRAN, T ;
PETERS, G ;
VANBEVEREN, C ;
TEICH, NM ;
VERMA, IM .
JOURNAL OF VIROLOGY, 1982, 44 (02) :674-682
[7]  
Davis L. G., 1986, BASIC METHODS MOL BI
[8]  
FAGUET GB, 1988, BLOOD, V71, P422
[9]   STUDY OF THE LEVELS OF EXPRESSION OF 2 ONCOGENES-C-MYC AND ONCOGENEN-C-MYB, IN ACUTE AND CHRONIC LEUKEMIAS OF BOTH LYMPHOID AND MYELOID LINEAGE [J].
FERRARI, S ;
TORELLI, U ;
SELLERI, L ;
DONELLI, A ;
VENTURELLI, D ;
NARNI, F ;
MORETTI, L ;
TORELLI, G .
LEUKEMIA RESEARCH, 1985, 9 (07) :833-&
[10]   MORPHOLOGICAL AND IMMUNOLOGICAL CHANGES OF HAIRY-CELL LEUKEMIA DURING ALPHA-2-INTERFERON THERAPY [J].
FRIDRIK, MA ;
WAHL, G ;
HERBINGER, W ;
SCHUTZENBERGER, W ;
GASTL, G ;
HUBER, C ;
KRONKE, M ;
HOPFEL, I .
BLUT, 1989, 58 (05) :261-264